Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study

Recruiting N/A Interventional Study
Lung Cancer Screening
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 74
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
2,635 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts. The study will enroll women between 50 and 74 years old, at risk for lung cancer due to their smoking history.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women aged from 50 to 74 years * who had smoked at least 20 pack years and quit less than 15 years ago * Had given their consent and accepted the need for a 2-year follow-up * Affiliated to the social security system Exclusion Criteria * Presence of clinical symptoms suggest…
Contacts

Marie-Pierre REVEL, PhD

+33 1 42 34 79 10

marie-pierre.revel@aphp.fr

CONTACT

Adèle BELLINO, MS

+33 1 58 41 11 95

adele.bellino@aphp.fr

CONTACT